The European Commission introduced the Critical Medicines Act to improve the supply and availability of essential medicines in the EU. While it includes ambitious proposals like the 'Buy European' mechanism, concerns remain about funding and the lack of a coordinated contingency stock. The proposal aims to boost European production and enhance joint procurement but faces criticism for its limited budget and omission of stockpiling strategies. Teljes cikk (Euronews.com)